Literature DB >> 10980108

A total fibrinogen deficiency is compatible with the development of pulmonary fibrosis in mice.

V A Ploplis1, J Wilberding, L McLennan, Z Liang, I Cornelissen, M E DeFord, E D Rosen, F J Castellino.   

Abstract

In addition to their well-known roles in hemostasis, fibrinogen (Fg) and fibrin (Fn) have been implicated in a number of other physiological and pathophysiological events. One of these involves the fibroproliferative response after acute lung injury, which is the focus of the current study. Mice with a total Fg deficiency (FG(-/-)) were generated by breeding heterozygous (FG(+/-)) pairs, each of which contained an allele with a targeted deletion of its Fg-gamma-chain gene. The resulting FG(-/-) animals did not possess detectable plasma Fg. FG(-/-) mice were then used to assess the roles of Fg and Fn in a bleomycin-induced acute lung injury model. Intratracheal administration of bleomycin in wild-type and FG(-/-) mice resulted in equivalent deposition of interstitial collagen and fibrotic lesions at days 7 and 14 after administration. This indicates that Fg and/or Fn are not essential for the development of bleomycin-induced pulmonary fibrosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10980108      PMCID: PMC1885710          DOI: 10.1016/S0002-9440(10)64582-8

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  41 in total

1.  Hypofibrinogenemia associated with a heterozygous missense mutation gamma153Cys to arg (Matsumoto IV): in vitro expression demonstrates defective secretion of the variant fibrinogen.

Authors:  F Terasawa; N Okumura; K Kitano; N Hayashida; M Shimosaka; M Okazaki; S T Lord
Journal:  Blood       Date:  1999-12-15       Impact factor: 22.113

2.  Hypofibrinogenemia in an individual with 2 coding (gamma82 A-->G and Bbeta235 P-->L) and 2 noncoding mutations.

Authors:  S O Brennan; A P Fellowes; J M Faed; P M George
Journal:  Blood       Date:  2000-03-01       Impact factor: 22.113

3.  The procoagulant state of the VX-2 tumor in rabbit lung in vivo--relative accumulation of fibrinogen, prothrombin, plasminogen, antithrombin and heparin cofactor II within the tumor.

Authors:  M W Hatton; B Ross; L Bardossy; S M Southward; M DeReske; M Richardson; M A Blajchman
Journal:  Thromb Haemost       Date:  1999-12       Impact factor: 5.249

4.  Polymerization of fibrinogen in murine bleomycin-induced lung injury.

Authors:  M A Olman; W L Simmons; D J Pollman; A Y Loftis; A Bini; E J Miller; G M Fuller; K E Rivera
Journal:  Am J Physiol       Date:  1996-10

5.  Missense mutations in the human beta fibrinogen gene cause congenital afibrinogenemia by impairing fibrinogen secretion.

Authors:  S Duga; R Asselta; E Santagostino; S Zeinali; T Simonic; M Malcovati; P M Mannucci; M L Tenchini
Journal:  Blood       Date:  2000-02-15       Impact factor: 22.113

6.  Mice lacking factor VII develop normally but suffer fatal perinatal bleeding.

Authors:  E D Rosen; J C Chan; E Idusogie; F Clotman; G Vlasuk; T Luther; L R Jalbert; S Albrecht; L Zhong; A Lissens; L Schoonjans; L Moons; D Collen; F J Castellino; P Carmeliet
Journal:  Nature       Date:  1997-11-20       Impact factor: 49.962

7.  Fibrinogen Baltimore I: polymerization defect associated with a gamma 292Gly----Val (GGC----GTC) mutation.

Authors:  S Bantia; S M Mane; W R Bell; C V Dang
Journal:  Blood       Date:  1990-12-01       Impact factor: 22.113

8.  Healing of corneal epithelial defects in plasminogen- and fibrinogen-deficient mice.

Authors:  W W Kao; C W Kao; A H Kaufman; K W Kombrinck; R L Converse; W V Good; T H Bugge; J L Degen
Journal:  Invest Ophthalmol Vis Sci       Date:  1998-03       Impact factor: 4.799

9.  Degradation of cross-linked fibrin by matrix metalloproteinase 3 (stromelysin 1): hydrolysis of the gamma Gly 404-Ala 405 peptide bond.

Authors:  A Bini; Y Itoh; B J Kudryk; H Nagase
Journal:  Biochemistry       Date:  1996-10-08       Impact factor: 3.162

10.  Inactivation of the gene for anticoagulant protein C causes lethal perinatal consumptive coagulopathy in mice.

Authors:  L R Jalbert; E D Rosen; L Moons; J C Chan; P Carmeliet; D Collen; F J Castellino
Journal:  J Clin Invest       Date:  1998-10-15       Impact factor: 14.808

View more
  35 in total

1.  The antifibrotic effects of plasminogen activation occur via prostaglandin E2 synthesis in humans and mice.

Authors:  Kristy A Bauman; Scott H Wettlaufer; Katsuhide Okunishi; Kevin M Vannella; Joshua S Stoolman; Steven K Huang; Anthony J Courey; Eric S White; Cory M Hogaboam; Richard H Simon; Galen B Toews; Thomas H Sisson; Bethany B Moore; Marc Peters-Golden
Journal:  J Clin Invest       Date:  2010-05-24       Impact factor: 14.808

2.  Protease-activated receptor-2 induces myofibroblast differentiation and tissue factor up-regulation during bleomycin-induced lung injury: potential role in pulmonary fibrosis.

Authors:  Keren Borensztajn; Paul Bresser; Chris van der Loos; Ilze Bot; Bernt van den Blink; Michael A den Bakker; Joost Daalhuisen; Angelique P Groot; Maikel P Peppelenbosch; Jan H von der Thüsen; C Arnold Spek
Journal:  Am J Pathol       Date:  2010-10-22       Impact factor: 4.307

3.  Fibrinogen has chaperone-like activity.

Authors:  Huadong Tang; Yan Fu; Yujie Cui; Yingbo He; Xing Zeng; Victoria A Ploplis; Francis J Castellino; Yongzhang Luo
Journal:  Biochem Biophys Res Commun       Date:  2008-12-04       Impact factor: 3.575

Review 4.  Genetic sequence analysis of inherited bleeding diseases.

Authors:  Flora Peyvandi; Tom Kunicki; David Lillicrap
Journal:  Blood       Date:  2013-10-11       Impact factor: 22.113

Review 5.  Role of the lysophospholipid mediators lysophosphatidic acid and sphingosine 1-phosphate in lung fibrosis.

Authors:  Barry S Shea; Andrew M Tager
Journal:  Proc Am Thorac Soc       Date:  2012-07

6.  Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice.

Authors:  N Hattori; J L Degen; T H Sisson; H Liu; B B Moore; R G Pandrangi; R H Simon; A F Drew
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

7.  The interaction between fibrinogen and zymogen FXIII-A2B2 is mediated by fibrinogen residues γ390-396 and the FXIII-B subunits.

Authors:  James R Byrnes; Clare Wilson; Anthony M Boutelle; Chase B Brandner; Matthew J Flick; Helen Philippou; Alisa S Wolberg
Journal:  Blood       Date:  2016-08-25       Impact factor: 22.113

Review 8.  New therapeutic targets in idiopathic pulmonary fibrosis. Aiming to rein in runaway wound-healing responses.

Authors:  Neil Ahluwalia; Barry S Shea; Andrew M Tager
Journal:  Am J Respir Crit Care Med       Date:  2014-10-15       Impact factor: 21.405

9.  Immunomodulatory effects of plasminogen activators on hepatic fibrogenesis.

Authors:  A A Higazi; M El-Haj; A Melhem; A Horani; O Pappo; C E Alvarez; N Muhanna; S L Friedman; R Safadi
Journal:  Clin Exp Immunol       Date:  2008-02-14       Impact factor: 4.330

10.  Functional dissection of Streptococcus pyogenes M5 protein: the hypervariable region is essential for virulence.

Authors:  Johan Waldemarsson; Margaretha Stålhammar-Carlemalm; Charlotta Sandin; Francis J Castellino; Gunnar Lindahl
Journal:  PLoS One       Date:  2009-10-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.